Strongyloides ratti: in vitro and in vivo activity of tribendimidine.
BACKGROUND: Strongyloidiasis is a truly neglected tropical disease, but its public health significance is far from being negligible. At present, only a few drugs are available for the treatment and control of strongyloidiasis. METHODOLOGY/PRINCIPAL FINDINGS: We investigated the activity of tribendim...
Main Authors: | Jennifer Keiser, Kai Thiemann, Yvette Endriss, Jürg Utzinger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC2217669?pdf=render |
Similar Items
-
Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis
by: Jennifer Keiser, et al.
Published: (2021-12-01) -
Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota
by: Pierre H.H. Schneeberger, et al.
Published: (2018-12-01) -
Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial.
by: Peter Steinmann, et al.
Published: (2008-01-01) -
Production and evaluation of monoclonal antibody against Strongyloides ratti
by: Aliyu, Mahmuda
Published: (2017) -
Immunological responses elicited by different infection regimes with Strongyloides ratti.
by: Steve Paterson, et al.
Published: (2008-06-01)